Philips Q2 Profit Drops, Orders Climb, Sees Growth Ahead; Stock Up

(RTTNews) - Shares of Philips Electronics NV (PHGFF.PK, PHG) were gaining around 4 percent in the morning trading in Amsterdam after the Dutch consumer electronics giant Monday reported higher orders and said it expects improved profitability in the second half, despite reporting lower profit in its second quarter. For the full year 2020, the company continues to expect a modest comparable sales growth and adjusted EBITA margin improvement.

Frans van Houten, CEO, said, "We expect to return to growth and improved profitability for the Group in the second half of the year, assuming we can convert our existing order book for the Diagnosis & Treatment and Connected Care businesses, elective procedures normalize, and consumer demand gradually improves."

In its efforts to fight against the Covid-19 pandemic, the company, in collaboration with its partners and suppliers, tripled the production of its hospital ventilators in the quarter. The company is on track to achieve the planned four-fold increase to 4,000 units per week in July 2020.

Philips is also on track to deliver over 400 million euros productivity savings for 2020 and 1.8 billion euros productivity savings for the 2017-2020 period.

For the second quarter, Philips' net income declined to 210 million euros from last year's 246 million euros. Earnings per share were 0.23 euro, down from 0.26 euro a year ago.

Adjusted attributable income from continuing operations was 0.35 euro per share, compared to 0.42 euro per share last year. Income from operations fell to 229 million euros from 350 million euros last year.

Adjusted EBITA margin was 9.5 percent of sales, down 230 basis points from last year. COVID-19 negatively impacted the adjusted EBITA margin by around 3 percentage points.

Sales declined 6 percent on a reported and comparable basis to 4.40 billion euros from prior year's 4.67 billion euros. It was estimated that COVID-19 had a negative impact of around 10 percentage points in sales.

As expected, sharp decrease in consumer demand and postponement of installations in hospitals, as well as elective procedures, due to COVID-19 resulted in a 19 percent comparable sales decrease for Personal Health businesses and a 9 percent decline for Diagnosis & Treatment businesses. This was partly offset by a strong 14 percent comparable sales growth for Connected Care businesses.

Comparable sales in both growth geographies as well as mature geographies decreased 6 percent, despite low-single-digit growth in Western Europe.

However, comparable order intake increased 27 percent in the quarter, driven by CT imaging systems, hospital ventilators and patient monitors.

In Amsterdam, Philips shares were trading at 45.04 euros, up 3.70 percent.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.